Sir2 activity
CA 2519161 A1 · Owner: Massachusetts Institute Of Technology · Inventors: Imai, Shin-Ichiro; Vaziri, Homayoun; Guarente, Leonard P.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention relates to methods of screening compounds that modulate cellular and organismal processes by modification of the activity of SIR2 and/or transcription factors, e.g. p53, particularly methods of screening for compounds that modify lifespan and/or metabolism of a cell or an organism by modulation of the activity of SIR2 and/or transcription factors, e.g. p53, and more particularly to methods of screening for compounds that modulate the activity of Sir2 and/or transcription factors e.g. p53. In, particular, the present invention relates to a method for screening a compound, by providing a test mixture comprising a transcription factor, Sir2, and a Sir2 cofactor with the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 8, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 8, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 8, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.